Abivax (AAVXF) Assets Average (2022 - 2026)

Abivax has reported Assets Average for 4 years, with the latest figure at $660.4 million in Q1 2026.

• On a quarterly basis, Assets Average rose 234.45% year-over-year to $660.4 million in Q1 2026; TTM through Mar 2026 was $660.4 million, a 234.45% increase from a year earlier, with the FY2025 full-year figure at $449.8 million, up 57.47% from the prior year.
• Assets Average was $660.4 million for Q1 2026 at Abivax, down from $721.2 million in the prior quarter.
• The five-year high for Assets Average was $721.2 million in Q4 2025, with the low at $101.0 million in Q4 2022.
• Average Assets Average over 4 years is $357.0 million, with a median of $214.5 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: Assets Average soared 112.33% in 2023, then soared 234.45% in 2026.
• Over 4 years, Assets Average stood at $101.0 million in 2022, then jumped by 112.33% to $214.5 million in 2023, then soared by 236.26% to $721.2 million in 2025, then declined by 8.44% to $660.4 million in 2026.
• The last three Assets Average figures came in at $660.4 million (Q1 2026), $721.2 million (Q4 2025), and $448.9 million (Q3 2025), per Business Quant data.